• Date: July 06, 2017

Two examples of the 23 projects that will be participating in the 2017 edition of CaixaImpulse are an easy-to-use lower limb exoskeleton to improve walking recovery for patients with spinal cord injuries (ABLE project) and a non-invasive technology to map cardiac arrhythmias and help choose the best treatment options (CORIFY project).

The projects were presented by their respective leaders during a press conference held on 5 July at the Palau Macaya, in Barcelona. The presentation was chaired by Jaume Giró, managing director of “la Caixa” Banking Foundation, and Marcelino Armenter, managing director of CriteriaCaixa and chairman of Caixa Capital Risc.

Giró detailed some of the news related to this year’s edition, such as the programme being extended to Portugal. In fact, one of the seven projects presented from Portugal has been selected. Led by researchers from the University of Coimbra, Biolocker is an oral care solution to prevent dental plaque from forming.

The second item of news is the participation of EIT Health, a leading European consortium in biomedicine innovation. According to Giró, the consortium contribute €210,000, which “has allowed us to increase the number of participating projects by three, in comparison to 2016”.

Armenter explained that CaixaImpulse offers support to help research transfer to the market, a process that is far from easy, “We help research projects on their way to the market, so that they can succeed and benefit society with their innovations.”

The call for proposals for the 2017 programme received a total of 80 proposals, 11% more than last year. So far, CaixaImpulse has spent 5.5 million euros and has promoted 58 initiatives, two of which have already become spin-offs, with five more in the process.

Picture caption: From left to right: Marcelino Armenter, managing director of CriteriaCaixa and chairman of Caixa Capital Risc; Josep Maria Font, ABLE project leader; Andreu Climent, CORIFY project leader; and Jaume Giró, managing director of “la Caixa” Banking Foundation.

More programme highlights

February 14, 2019

GlyCardial Diagnostics wins Horizon 2020 funding

Apo J-Glyc, a project selected in CaixaImpulse 2015, is now operating as a company named GlyCardial Diagnostics.

February 12, 2019

“The entrepreneur is the one who has to choose, whether they get it right or make mistakes”

Roger Gomis from IRB talks to us about what CaixaImpulse means to him and explains more about his role as mentor.

February 04, 2019

Applications open for CaixaImpulse’s 2019 call

CaixaImpulse is seeking 25 innovative health and biomedical projects to support and develop starting in 2019.